用于预防复发性尿路感染的肠道药物
D Carolina Ochoa1, Rion Healy1
1Bristol Urological Institute, Southmead Hospital, Bristol, UK.
European urology focus
|August 20, 2024
概括
静脉内疗法,包括糖氨基甘油层增强剂和氨基甘油酸抗生素,可安全有效地预防复发性尿路感染 (rUTIs). 这些治疗方法有助于通过提供标准口服抗生素的替代方案来打击抗生素耐药性.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 经常性尿路感染 (rUTIs) 显著影响患者的生活质量.
- 目前的抗生素治疗有助于增加抗菌素耐药性.
- 迫切需要替代疗法来预防RUTI.
研究的目的:
- 审查用于预防RUTI的静脉注射剂的证据.
- 为了评估抗生素和非抗生素的肠道治疗选择.
- 确定RUTI预防的安全和有效策略.
主要方法:
- 现有科学文献的小型综述.
- 对用于预防RUTI的静脉注射剂的研究的评估.
- 对糖氨基甘氨酸补充剂和特定抗生素的证据分析.
主要成果:
- 补充葡萄糖氨基酸糖分层的肠道药物得到了当前证据的支持.
- 氨基甘油酸抗生素在静脉注射时,在预防RUTI方面显示出安全性和有效性.
- 这两个类别都代表了系统性抗生素预防的可行的替代方案.
结论:
- 肠道治疗是预防RUTI的一个有希望的方法.
- 增强膀糖氨基酸层的药物和氨基糖化物是有效的选择.
- 这些静脉注射方法有助于在RUTI治疗中控制抗生素耐药性.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
153
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
153
Surface Membrane Barriers
1.1K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K
Urinary Bladder
502
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
502
Hand hygiene
3.1K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Hand washing...
3.1K
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Drug Elimination by Renal Route: Tubular Secretion
2.3K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.3K


